CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 48 filers reported holding CIDARA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,320,000 | -15.4% | 300,000 | 0.0% | 0.05% | -20.0% |
| Q2 2018 | $1,560,000 | +30.0% | 300,000 | 0.0% | 0.06% | +17.6% |
| Q1 2018 | $1,200,000 | -41.2% | 300,000 | 0.0% | 0.05% | -45.2% |
| Q4 2017 | $2,040,000 | -16.0% | 300,000 | 0.0% | 0.09% | -17.0% |
| Q3 2017 | $2,430,000 | +8.0% | 300,000 | 0.0% | 0.11% | -1.8% |
| Q2 2017 | $2,250,000 | -3.8% | 300,000 | 0.0% | 0.11% | -15.6% |
| Q1 2017 | $2,340,000 | -25.0% | 300,000 | 0.0% | 0.14% | -35.4% |
| Q4 2016 | $3,120,000 | +9.0% | 300,000 | +20.0% | 0.21% | +16.8% |
| Q3 2016 | $2,863,000 | +11.1% | 250,000 | 0.0% | 0.18% | -6.3% |
| Q2 2016 | $2,578,000 | -18.8% | 250,000 | 0.0% | 0.19% | -28.2% |
| Q1 2016 | $3,175,000 | -26.0% | 250,000 | 0.0% | 0.27% | -18.2% |
| Q4 2015 | $4,290,000 | +22.6% | 250,000 | -9.1% | 0.32% | +14.4% |
| Q3 2015 | $3,498,000 | -0.2% | 275,000 | +10.0% | 0.28% | +10.9% |
| Q2 2015 | $3,505,000 | – | 250,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,677,194 | $819,000 | 1.02% |
| BVF INC/IL | 6,861,127 | $3,352,000 | 0.16% |
| 5AM Venture Management, LLC | 1,134,511 | $554,000 | 0.14% |
| Knott David M Jr | 635,254 | $310,000 | 0.13% |
| Nantahala Capital Management | 4,819,090 | $2,355,000 | 0.12% |
| West Family Investments, Inc. | 368,910 | $180,000 | 0.07% |
| Stonepine Capital Management, LLC | 208,443 | $102,000 | 0.05% |
| JEPPSON WEALTH MANAGEMENT, LLC | 181,075 | $88,000 | 0.04% |
| Ground Swell Capital, LLC | 11,397 | $6,000 | 0.01% |
| Point72 Asset Management, L.P. | 4,200,000 | $2,052,000 | 0.01% |